𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Growth-inhibitory effects of combination chemotherapy for human pancreatic cancer cell lines

✍ Scribed by Seiki Matsuno; Hirotake Hisano; Masao Kobari; Satoshi Akaishi


Publisher
John Wiley and Sons
Year
1990
Tongue
English
Weight
533 KB
Volume
66
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Inhibitory effects of evodiamine on the
✍ Shu-Fen Kan; William J. Huang; Lie-Chwen Lin; Paulus S. Wang πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 French βš– 563 KB

## Abstract Evodiamine, isolated from a Chinese herbal drug named Wu‐Chu‐Yu, possesses many biological functions. Recently, it has been reported that Wu‐Chu‐Yu exerts an antiproliferative effect on several cancers. Prostate carcinoma initially occurs as an androgen‐dependent tumor and is the second

Growth inhibition of human pancreatic ca
✍ Kei-ichiro Kita; Seiji Saito,; Cintia Y. Morioka; Akiharu Watanabe πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 French βš– 129 KB πŸ‘ 2 views

About 90% of human pancreatic cancers carry K-ras point mutation, which may play an important role in tumorigenesis. We investigated the inhibitory effects of anti-sense oligonucleotides targeting K-ras point mutation on the growth of cultured human pancreatic cancer cells. Eight human pancreatic ca

Growth dependency of a new human pancrea
✍ Takayuki Yamada; Fumikazu Okajima; Masakazu Adachi; Susumu Ohwada; Yoichi Kondo πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 French βš– 252 KB πŸ‘ 2 views

We established a new human pancreatic cancer cell line from the malignant ascites of a patient with pancreatic cancer and called it YAPC. Cytogenetic and morphological analysis indicated that this cell line is monoclonal and of human origin. YAPC cells grow in nude mice, resulting in the formation o

Inhibitory effects of a cholecystokinin
✍ Hideki Morimoto; Dr. Yoshinori Nio; Michihiko Tsubono; Chen-Chiu Tseng; Kazuya K πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 676 KB

The effects of cholecystokinin (CCK) and a CCK antagonist, loxiglumide (CR-1505), on four freshly separated and six xenografted human pancreatic cancers, were investigated. The level of DNA synthesis in only one of five tested pancreatic cancers was enhanced by CCK at concentrations of 0.01-10 nM, w